AK Medical Holdings Limited (1789.HK)
HKSE · HKD · Healthcare · Medical Devices
HK$4.55 (+1.34%) as of
Key statistics
- Market cap
- 4.80B
- P/E (TTM)
- 11.96
- Forward P/E
- 9.27
- EPS (TTM)
- 0.380
- Dividend yield
- 2.63%
- 52-week range
- 4.200 – 7.150
- Beta
- -0.24
- Revenue (TTM)
- 1.55B
- Profit margin
- 24.16%
- Analyst target
- HK$7.86
- Volume
- 3.49M
About AK Medical Holdings Limited
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in the People's Republic of China, the United Kingdom, and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, as well as customized joint, pelvic, spinal and trauma implant products and customized value-added surgical services and orthopedic surgical robots. The company also distributes third party orthopedic products; and offers surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is based in Beijing, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Beijing, China
- Employees
- 1,004
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.